ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• How TrialKit's API Architecture Enables Custom Clinical Workflows Without Added Complexity

  Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.

• Driving Enrollment Predictability In Clinical Trial Timelines

  Missed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.

• The Regulatory Binder Checklist For Clinical Trial Sites

  By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.

• How Technology Can Empower CAR T-Cell Therapy Clinical Trials

  Explore how innovative technologies are pushing advancements in CAR T-cell therapy, enhancing patient outcomes, and streamlining trial processes.

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

• Gradually Investing In Direct Data Capture Is Inevitable

  Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

• Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?

  If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?

• Top 10 HEOR Trends Report

  Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

• Advancing The Implementation Of ICH E17

  Explore the ICH E17 guidelines that provide a harmonized framework for designing and conducting multiregional clinical trials (MRCTs) to meet the regulatory expectations of multiple regions.